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Evaluation of a new biodegradable membrane to prevent gingival
ingrowth into mandibular bone defects in minipigs
Abstract
OBJECTIVE: The aim of this study was to test whether a synthetic, biodegradable membrane made of
polyethylene glycol (PEG) can prevent soft-tissue ingrowth into alveolar defects. MATERIAL AND
METHODS: In each of 16 minipigs, three mandibular premolars were bilaterally extracted. Three
months later, acute standardized defects (diameter 8 mm, depth 8 mm) were prepared. Four treatment
modalities were randomly allocated to the defects: (1) PEG membrane plus collagen sponge, (2)
polylactide (PLA) membrane plus collagen sponge, (3) collagen sponge alone, and (4) empty defect.
Animals were sacrificed at 10 days (n=5), 21 days (n=5), or 2 months (n=6) after treatment. Qualitative
and quantitative histological evaluations of soft-tissue ingrowth and bone regeneration were performed
on nondecalcified ground sections. For statistical analysis, the Mann-Whitney-Wilcoxon test, the
Kruskal-Wallis, and the paired t-test were applied. P-values were adjusted using the Dunnett-Hsu
adjustment. RESULTS: At 10 days, the PEG membrane group showed the least soft-tissue ingrowth
(mean value -0.75 mm; range -1.35 to -0.10), followed by the PLA membrane group -0.18 mm (-0.80 to
0.44), the collagen group 0.04 mm (-0.65 to 0.73), and the empty defects 0.60 mm (-0.08 to 1.29).
Statistically significant differences were observed between the PEG membrane group and the empty
defects (P<0.05). At 21 days, the highest percentage of newly formed bone was found in the PEG
membrane group (mean 28.4%; range 21.6-35.2) compared with 23.7% (16.9-30.5; PLA membrane),
15.2% (8.2-22.2; collagen group), and 21.6% (14.5-28.8; empty defects). Statistically significant
differences were only found between the PEG membrane group and the collagen group (P<0.05). At 2
months, the tested parameters revealed no statistically significant differences between the groups.
CONCLUSION: The experimental PEG membrane applied in the present study successfully prevented
collapse of the covering soft tissues to a degree similar to the PLA membrane. The combination of a
collagen sponge and the PEG membrane showed the least soft-tissue ingrowth at 10 days and promoted
more bone formation at 21 days.
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ABSTRACT 
 
Objective: The aim of this study was to test whether a synthetic, biodegradable membrane 
made of polyethyleneglycole (PEG) can prevent soft tissue ingrowth into alveolar defects.  
Material and Methods: In each of 16 minipigs the 3 mandibular premolars were bilaterally 
extracted. Three months later, acute standardized defects (diameter 8mm, depth 8mm) were 
prepared. Four treatment modalities were randomly allocated to the defects: 1) PEG 
membrane plus collagen sponge, 2) polylactide (PLA) membrane plus collagen sponge, 3) 
collagen sponge alone, 4) empty defect. Animals were sacrificed at 10 days (n=5), 21 days 
(n=5), or 2 months (n=6) after treatment. Qualitative and quantitative histological evaluations 
of soft tissue ingrowth and bone regeneration were performed on non-decalcified ground 
sections. For statistical analysis the Mann-Whitney-Wilcoxon test, the Kruskal-Wallis, and 
the paired t-test were applied. P-values were adjusted using the Dunnett-Hsu adjustment. 
Results: At 10 days, the PEG membrane group showed the least soft tissue ingrowth (mean 
value -0.75mm; range -1.35 to -0.10), followed by the PLA membrane group -0.18mm (-0.80 
to 0.44), the collagen group 0.04mm (-0.65 to 0.73), and the empty defects 0.60mm (-0.08 to 
1.29). Statistically significant differences were observed between the PEG membrane group 
and the empty defects (p<0.05). At 21 days, the highest percentage of newly formed bone was 
found in the PEG membrane group (mean 28.4%; range 21.6 to 35.2) compared to 23.7% 
(16.9 to 30.5; PLA membrane), 15.2% (8.2 to 22.2; collagen group), and 21.6% (14.5 to 28.8; 
empty defects). Statistically significant differences were only found between the PEG 
membrane group and the collagen group (p<0.05). At 2 months, the tested parameters 
revealed no statistically significant differences between the groups. 
Conclusion: The experimental PEG membrane applied in the present study successfully 
prevented collapse of the covering soft tissues to a degree similar to the PLA membrane. The 
combination of a collagen sponge and the PEG membrane showed the least soft tissue 
ingrowth at 10 days and promoted more bone formation at 21 days. 
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INTRODUCTION 
 
Numerous preclinical and clinical studies have described the principle of guided bone 
regeneration (GBR) and a wide range of resorbable and non-resorbable membranes have been 
investigated over the last two decades (Dahlin et al. 1988, Hämmerle et al. 1992, Linde et al. 
1993, Sandberg et al. 1993, Schenk et al. 1994, Hammerle & Jung 2003). The principle of 
excluding the connective tissue from a bone area has been used for bone augmentation 
procedures in combination with or without simultaneous implantation (Lang, et al. 1994, 
Buser et al. 1990, Dahlin et al. 1991). However, several problems are associated with the use 
of membranes. Non-resorbable membranes tend to get exposed, need a second stage surgery 
for removal, and can induce severe cellular reactions (Simion et al. 1994, Aaboe et al. 1998). 
On the other hand, resorbable membranes have become a reliable alternative, as they are not 
associated with these difficulties (Mayfield et al. 1997, Zitzmann et al. 1997). However, when 
they were compared to non-resorbable membranes, the non-resorbable membranes better 
preserved the marginal bone levels in peri-implant bone regeneration (Zitzmann et al. 2001). 
Several animal and clinical studies showed gain in marginal bone, using resorbable 
membranes in combination with an underlying, osteoconductive membrane supporting 
material, which avoided the collapse of the barriers (Hockers et al. 1999, Brunel et al. 2001, 
Hämmerle & Lang 2001, Zitzmann et al. 2001, Strietzel et al. 2006). According to these 
investigations, two main parameters are desirable: the barrier function and the space-
maintenance.  
Collagen membranes, as the most often used type of resorbable membranes, lack enough 
stiffness for space maintenance and tend to collapse (Strietzel et al. 2006). Additionally, 
collagen-membranes are prefabricated in standard sizes and need to be adapted to the 
morphology of the surgical site.  
Hence, this individualization of form and size is a time-consuming and tricky procedure, 
which limits the use of membranes in every day clinical practice (Pirhonen et al. 2006).  
Synthetic resorbable membranes consisting of poly(DL-lactide) (PLA) and lactide/glycolide 
copolymers have been developed in the late eighties and have been investigated in several 
animal and clinical studies (Magnusson et al. 1988, Fleisher et al. 1988, Gottlow et al. 1994). 
One of these membranes, made of PLA dissolved in N-metyhl-2-pyrrolidone (NMP) 
(Atrisorb®, Collagenex Pharmaceuticals, Inc, Newtown, USA), was tested by several authors 
(Polson et al. 1995, Coonts et al. 1998, Hou et al. 2004). This barrier membrane is applied 
customized in a liquid manner, therefore eliminating the cutting, trimming or handling of 
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preformed barriers. This PLA membrane was shown to have good tissue response, 
biocompatibility and to be an effective barrier in promoting bone regeneration in periodontal 
defects (Coonts et al. 1998).  
Recently, the function of a synthetic hydrogel made of polyethylene glycol (PEG) as a barrier 
membrane for GBR has been evaluated (Jung et al. 2006). In a preclinical study in the rabbit 
calvaria, an in situ formed PEG was compared to an ePTFE membrane. It was concluded that 
the PEG membrane could be successfully used as a biodegradable barrier membrane in the 
treatment of non-critical-size defects in the rabbit skull, and that it lead to similar amounts of 
bone regeneration as an ePTFE membrane (Jung et al. 2006). Based on the finding that the 
membrane can successfully be used to regenerate bone, the question arises regarding its 
stiffness and its ability to prevent collapsing. 
The aim of this study was to test the barrier function of a synthetic, biodegradable hydrogel 
membrane (PEG membrane) in acute standardized mandibular bone defects in minipigs.  
The hypothesis was that the PEG membrane (test) would prevent soft tissue proliferation into 
a standardized bone defect. This hypothesis was assumed to be validated if the soft tissue 
proliferation into the defects filled with a collagen sponge and protected by the PEG 
membrane was lower than the soft tissue proliferation in the defects that were left empty and 
not covered with a membrane (negative control) at 10 and 21 days. 
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MATERIALS AND METHODS 
 
Animals 
This study was designed as a randomized experimental study employing 16 female minipigs 
(Göttingen MiniPig, Ellegaards, Denmark). At the beginning of the study, the animals were 
about 18 months old and weighed between 25 and 40 kg. The study was performed at the 
Experimental Department at the University Hospital of Malmö, according to the guidelines of 
the Swedish law of animal keeping. The minipigs were kept under humid diet. The protocol 
was approved by the Malmö/Lunds djurförsöksetiska nämnd, ethical committee, Lund 
(M262-03). 
 
Surgery 
All surgical procedures were performed under general anesthesia in an operating room. For 
premedication, the following agents were used: prophylactic antibiotic treatment with 
Streptocillin®vet., 250 mg/ml + 200 mg/ml (Boehringer Ingelheim, Denmark),was started the 
day before the tooth extraction procedure and was continued for 7 consecutive days. Each 
animal received an injection of Temgesic®, 0,3 mg/ml (Schering-Plough, Belgium) for 
analgesia on the day of the surgery 1 and on the next 3 days. Subsequently, the minipigs were 
anesthetized according to a standard procedure using Ketalar® 50mg/ml (Pfizer, Sweden), 
and Midazolam Hamelin 5 mg/ml (Pharma Hamelin, Germany). After disinfection of the 
surgical site with 0.2% chlorhexidine solution (Corsodyl, GlaxoSmithKline, Brentford, 
Middlesex, UK), local anesthetic (Lidocaine HCl 2% with epinephrine 1:100,000; Henry 
Schein Inc., Port Washington, NY, USA) was administred by infiltration at the respective 
buccal and lingual sites. All premolars (P2, P3, and P4) were bilaterally extracted from the 
lower jaw during the first surgery.  
Three months later defect preparation and regeneration surgery (surgery 2) was performed on 
both sides of the mandible in all minipigs. Following a mid-crestal incision from the M1 to 
the canine, a full-thickness mucoperiostal flap was prepared to the buccal and lingual alveolar 
plate, approximately 1 to 2 mm below the mucogingival junction. All granulation tissue was 
carefully removed. The edentulous osseous ridge was flattened in order to obtain a width of a 
least 10 mm. Two defects (at a distance of 12 mm between them and 7 mm to M1) were 
drilled on each side of the mandible to a depth and width of 8 mm (Fig. 1). Due to insufficient 
ridge height, complications sometimes arose by perforation the top of the mandibular canal. 
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The following four treatment modalities were randomly allocated to the four surgically 
created defects: 
 
Test:  a collagen-cone (TissuCone E, Baxter, Deerfield, USA) and a polyethyleneglycol 
 membrane (PEG, Institut Straumann AG, Basel, Switzerland) 
Control 1:  a collagen-cone (TissuCone E, Baxter, Deerfield, USA) and a polylactide 
 membrane (PLA, Atrisorb®, Collagenex Pharmaceuticals, Inc, Newtown, USA) 
Control 2:  a collagen-cone (collagen, TissuCone E, Baxter, Deerfield, USA) 
Control 3:  no filler, no membrane (empty defect) 
 
At the test sites, and the control 1 and 2 sites collagen-cones were placed in the defects 1 mm 
below the alveolar crest (Fig. 2). No further treatment was applied for the control 2 sites. The 
control sites 3 were left empty and without a membrane. Bleeding was allowed to form a 
blood clot (Fig. 2). Two titanium pins were placed 1mm below the alveolar crest on the 
buccal and lingual side of each defect. At the test sites, the PEG membrane was applied by a 
syringe on the collagen-cones and the surrounding alveolar ridge in order to completely cover 
the defect and to extend 2 mm beyond the defect margins. Within less than 1 minute the 
degradable synthetic membrane gelled and stabilized (Fig. 3). Similarly, the PLA membrane 
in control 1 sites was applied on the collagen-cone and on the alveolar crest. After placement, 
sterile saline solution was used for approximately 30 seconds to start the precipitation of the 
membrane. This was determined by the surface beginning to opacify (Fig. 4). Following 
irrigation, meticulous removal of the periosteum was performed in the soft tissue area coming 
in contact with the standardized defect. Closure of the flaps was then accomplished by placing 
horizontal mattress sutures (Gore-Tex® sutures, W.L. Gore & Assoc., Flagstaff, USA). The 
sutures were removed 10 days after surgery 2. 
 
Sacrifice 
10 days (5 animals), 21 days (5 animals) or two months (6 animals) following surgery 2, the 
animals were painlessly sacrificed by lethal doses of injected Pentotal® (pentobarbital 
veterinary, Apoteksbolaget, Sweden).  
 
Macroscopic observations 
At the day of sacrifice, a macroscopic observation of the implanted sites was performed. Any 
local inflammation, necrosis, hemorrhage or any other lesion was recorded. Immediately after 
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dissection, the 2 hemi-mandibles were block resected and fixed by immersion in 10 % 
formaldehyde in phosphate buffer at pH 7. 
 
Histology and histomorphometry 
Histological preparation  
X-rays recordings were performed for each site in order to accurately determine the cutting 
planes. The 64 sites (4 per animal) were dehydrated in a series of graded alcohol solutions and 
embedded in PMMA (polymethylmetacrylate, Merck AG, Darmstadt, Germany). From each 
specimen, two central orofacial sections through the defect were prepared for histological 
assessment. The longitudinal sections through the defect of 50 to 60 µm thickness were 
obtained by a microcutting and grinding technique adapted by Donath (Donath & Breuner 
1982). Thereafter, the sections were stained with McNeals tetrachrome solution and toluidine 
blue (Schenk et al. 1984).  
 
Criteria for histological interpretation 
A qualitative analysis was performed with a stereoscope (Nikon Eclipse 90i, Nikon, Egg, 
Switzerland), evaluating the different components (mineralized bone, non-mineralized tissue, 
pins, membranes, and teeth) according to the standard nomenclature of the International 
Society for Stereology (Exner 1987). 
 
Histomorphometrical analysis 
Computer-assisted histometric measurements were obtained using an automated image 
analysis system (Visiopharm Integrator System®, Visiopharm A/S, Hørsholm, Denmark), 
coupled with a video camera (Nikon Digital Sight DS-5Mc, Nikon, Egg, Switzerland) 
mounted on a light microscope (Nikon Eclipse 90i, Nikon, Egg, Switzerland). The borders of 
the newly formed bone area including bone marrow within the defects were manually marked 
on the computer screen using a digital pen. Within this region of interest (ROI), the tissue was 
digitally classified into mineralized bone, non-mineralized tissue, pins, membranes, and teeth. 
Subsequently, the total number of pixels and the number of pixels allocated to bone and non-
mineralized tissue within the ROI were counted by the software. All measurements were done 
by two blinded examiners and thereafter compared and discussed to aim for congruence. The 
following parameters were calculated (Fig. 5): 
• The average soft tissue depth (mm) (calculated as an average of five vertical 
measurements taken between the level of the original bone crest and the most apical 
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limit of soft tissue ingrowth at equal intervals between the buccal and lingual borders 
of the initial bone defect)  
• The soft tissue ingrowth (%) with respect to the initial bone defect area 
• The newly formed bone (%) with respect to the initial bone defect area 
• The position of the most apical point of the soft tissue ingrowth (mm) 
 
 
STATISTICAL ANALYSIS 
 
Data analyses were performed with SAS software (SAS Institute, Cary, USA). Measured 
parameters were summarized in terms of mean values and standard deviations. The one to one 
relationship between the measured parameters and each of the factors (individual, side, 
position and treatment) was examined using the Mann-Whitney-Wilcoxon test (for factors 
with two levels) or the Kruskal-Wallis (for factors with more than two levels). Unadjusted 
comparisons of the means of the measured parameters between the PEG membrane treatment 
and each of the other treatments were explored using the paired t-test. Generalized linear 
regression models were used to calculate the adjusted means of the different measurements 
for the comparison between treatments. The means were adjusted for the effect of the 
individual and the side within the mandible. The factor position was not significant in the 
univariate or multivariate comparisons and therefore not included in the final model. P-values 
were adjusted using the Dunnett-Hsu adjustment for multiple comparisons. Statistical 
significance was set at the alpha level of 0.05 and all tests were two-sided.  
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RESULTS 
 
Clinical findings 
The pigs were healthy and no systemic complications occurred during the entire study. 
Generally speaking the postoperative wound healing was good. At the time of suture removal, 
minor soft tissue dehiscences (defined as incomplete soft tissue closure) were observed in all 
groups. Subsequently, the dehiscences healed over with new soft tissue and further healing 
was uneventful.  
 
Descriptive histology 
 
Ten-day observations 
All 5 PEG membranes successfully prevented soft tissue ingrowth. The apical extension of 
the soft tissue was consistently above (coronal) the original defect level (Fig. 6). Four 
membranes were almost intact. In one specimen, due to the histological processing, the 
membrane had almost completely disappeared and only minor remnants of the membrane 
could be seen. At 3 of the 5 PLA membrane sites the level of the covering soft tissue was at 
the original bone crest. The remaining 2 sites revealed minor collapse of the membranes with 
concomitant invagination of the covering soft tissue. In both groups, the defects were almost 
completely filled with a honeycomb-like structure representing the collagen sponge. In 2 
control sites, the collagen cones prevented soft tissue ingrowth in the absence of membranes. 
Whereas in the other 3 defects only parts of the original collagen sponge remained and, hence, 
more pronounced soft tissue ingrowth had taken place. Marked soft tissue ingrowth was 
detected in all 5 untreated defects. New bone apposition was observed along the walls and the 
bottom of the original defects in all groups. Additionally, new bone was formed adjacent to 
the defects on the alveolar crest, sometimes covering the pins. 
 
Twenty-one-day observations 
At this time, complete wound closure by a structured gingival tissue was observed in all 
groups. Almost complete bone fill was found in the two membranes groups (PEG, PLA) (Fig. 
7).  Parts of the PEG and PLA membranes were still detectable. The soft tissue ingrowth was, 
therefore, minimal in these groups. In 1 site with a PLA membrane most of the original defect 
was filled with non-mineralized tissue. At this site no old bone was present between the 
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bottom of the prepared defect and the roof of the mandibular canal. Here a perforation into the 
mandibular canal and proximity with the root of a canine were observed. In the 2 non-
membrane groups new bone apposition was detected in the apical and lateral parts of the 
original defect. Soft tissue ingrowth into the original defect took place in all sites in these 2 
groups.  
 
Two-month observations 
The specimens looked similar for all 4 treatment modalities (Fig. 8). Complete bone fill of the 
original defect was a consistent finding. Most original defects showed bone apposition above 
the level of the original bone crest. Small differences were detected between the animals. In 
some of the defects some bone marrow had already developed in the central portion. 
 
Histomorphometry 
 
Ten-day observations 
Regarding the soft tissue ingrowth, the PEG membrane group showed the lowest values: 
adjusted mean=-0.75mm (95% confidence interval=-1.35 to -0.10), compared to -0.18mm (-
0.80 to 0.44) for the PLA membrane group, 0.04mm (-0.65 to 0.73) for the collagen group, 
and 0.60mm (-0.08 to 1.29) for the empty defects (Table 1, Fig. 9). Generally more soft tissue 
ingrowth was observed at the 2 non-membrane-groups. Statistically significant differences 
were found between the PEG membrane group and the untreated defects. The ratio of soft 
tissue area ingrowth to original defect area was also lowest for the PEG membrane group with 
a mean value of 0.1% (-10.9 to 11.1), compared to 0.8% (-10.7 to 11.8) (PLA membrane), 
8.5% (-3.6 to 20.7) (collagen), and 16.9% (4.7 to 29.0) for the empty defects (Fig. 10). The 
most apical point of soft tissue ingrowth was always outside of the original defect in the PEG 
membrane group with a mean value of -0.90mm (-2.97 to 1.12), compared to 0.19mm (-1.86 
to 2.23) for the sites treated with a PLA membrane, 0.19mm (-1.86 to 2.23) for sites treated 
with a collagen sponge, and 2.82mm (0.55 to 5.09) for empty defects. No statistically 
significant differences between the test group and the other treatment modalities were found 
for the last 2 described variables. 
 
Twenty-one-day observations 
The lowest values for soft tissue ingrowth were observed for the PEG membrane group, 
adjusted mean=0.23mm (95% confidence interval=-0.38 to 0.84), compared to 0.63mm (0.01 
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to 1.24) for the PLA membrane group, 1.04mm (0.41 to 1.68) for the collagen group, and 
0.14mm (-0.51 to 0.78) for empty defects (Table 2, Fig. 9). The ratio of soft tissue area 
ingrowth to original defect area was also lowest for the PEG membrane group with a mean 
value of 7.0% (-3.4 to 17.4), compared to 13.8% (3.4 to 24.3) for the PLA membrane group, 
23.3% (12.7 to 34.1) for the collagen group, and 9.3% (-3.6 to 18.3) for the empty defects 
(Fig. 10). The most apical point of soft tissue ingrowth measured for the PEG membrane 
group was 1.64mm (0.2 to 3.3), compared to 2.24mm (0.62 to 3.87) for the PLA membrane 
group, 4.94mm (3.27 to 6.61) for the collagen group, and 2.77mm (1.07 to 4.50) for the 
empty defects. There were no statistically significant differences regarding the parameters 
cited above. Among the evaluated treatment options, the highest percentage of newly formed 
bone was found for the PEG membrane group (28.4%; 21.6 to 35.2) compared to the PLA 
membrane group (23.7%; 16.9 to 30.5), to the collagen group (15.2%; 8.2 to 22.2), and to the 
sites left empty (21.6%; 14.5 to 28.8) (Fig. 11). Statistically significant difference was only 
found between the PEG membrane group and the collagen group. 
 
Two-month observations 
The adjusted mean values for the soft tissue area (gingival ingrowth) were negative for all 4 
treatment modalities. This indicates that the newly developed bone was coronal to the original 
bone crest (Table 3, Fig. 8). 
The area of newly formed bone varied between 55.6% (47.2 to 63.9) for the PEG membrane 
group, 54.9% (46.5 to 63.2) for the PLA membrane group, 60.0% (51.2 to 68.8) for the 
collagen group, and with lowest bone regeneration for empty defects (48.4%; 39.8 to 57.1) 
(Fig. 11). All tested parameters revealed no statistically significant differences between the 
groups (Fig. 9/10). 
 
 
DISCUSSION 
 
The results of the present experiment demonstrated a tendency for the PEG membrane to 
better perform in terms of prevention of soft tissue ingrowth and promotion of bone 
regeneration. No statistically significant differences to the other membrane were found.  
The most effective prevention of soft tissue ingrowth was achieved by the PEG membrane. 
Statistically significant differences were obtained between the PEG membrane group and the 
untreated defects regarding soft tissue ingrowth at 10 days. The ratio of soft tissue area 
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ingrowth to original defect area was also lowest for the PEG membrane group, but without 
statistically significant differences relative to the other groups. No significant differences 
were found between the PLA membrane group, the collagen sponge group and the empty 
group regarding soft tissue ingrowth and soft tissue area. 
Theoretically, membranes need to fulfill two criteria in order to successfully prevent soft 
tissue ingrowth: i) prevent cells derived from the covering soft tissue flap from migrating into 
the area intended for bone formation underneath the membrane (cell occlusive function), ii) 
provide sufficient mechanical stability in order to maintain the space underneath the 
membrane. 
The cell-occlusive function of a PEG membrane was already evaluated in a preclinical study 
in the rabbit calvaria (Jung et al. 2006). Three treatment modalities (HA/TCP plus PEG 
membrane, HA/TCP plus ePTFE membrane, and HA/TCP alone) were applied. The two 
membrane groups showed significantly more bone formation compared to the negative 
control (HA/TCP alone). The results demonstrated that the PEG membrane could be used as a 
biodegradable barrier membrane in the treatment of non-critical-size defects in the rabbit 
skull, leading to similar amounts of bone regeneration as an ePTFE membrane. This has been 
confirmed in a rat experiment (Wechsler et al. 2007). Using a subcutaneous implant model in 
rats the barrier function of the PEG-based hydrogel was evaluated over time. The PEG 
membranes were implanted in dorsal subcutaneous pockets. After healing periods of up to 7 
months, explants were collected. Histological analysis revealed that for at least 4 months 
cellular infiltration into the membrane explants was lower than 1% of that of the positive 
controls (fibrin sponges). These results indicated that the PEG membrane has the potential to 
be used as a GBR membrane (Wechsler et al. 2007). In an earlier study, a PLA membrane 
was tested in buccal dehiscence defects in dogs (Coonts et al. 1998). The PLA membrane 
barrier function was compared to sham-operated control sites in a split-mouth design. It was 
concluded, that the PLA membrane was effective in promoting bone and cementum 
regeneration in periodontal defects and therefore proved its barrier function.  
Previous studies have investigated the ability of membranes to withstand the mechanical 
pressure exerted by the covering flap during healing following GBR surgery (Hämmerle et al. 
1992, Schmid et al. 1997, Lundgren et al. 1998, Slotte et al. 1999). In the study mentioned 
above (Jung et al. 2006), the use of the PEG membrane was leading to similar amounts of 
bone regeneration as an ePTFE membrane. Hence, the PEG membrane demonstrated 
sufficient mechanical stability in combination with HA/TCP.  
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In a sheep model round cranial defects were prepared and 6 different treatment modalities 
tested (Schmidmaier et al. 2006). The results demonstrated that the 2 polylactide membranes 
successfully prevented soft tissue prolapse and allowed new bone to form inside the defect. 
The collagen sponges used in the present study were almost completely intact at 10 days, 
exhibiting a honeycomb-like structure. Up to this time point, the collagen sponges stabilized 
the soft tissue on its original level at the bone crest. At 21 days, however, no remnants of the 
collagen sponges were detected and collapse of the soft tissue into the defect had occurred. 
This collapse was more pronounced in the collagen group than in the other treatment groups. 
These results are in agreement with previous clinical studies, which revealed that the collagen 
was not able to withstand the soft tissue pressure and to sufficiently support membranes 
(Buser et al. 1990, Buser et al. 1993). 
In the untreated defects, remnants of the blood clot were observed at 10 days. The most 
pronounced soft tissue ingrowth was observed in these sites at 10 and 21 days (with 
statistically significant differences to the PEG membrane). The influence on guided bone 
regeneration of barriers with varying occlusiveness was tested in a rat experiment (Lundgren 
et al. 1998). Special devices were fixed on the top of the skull. These devices were open 
towards the skull. Towards the soft tissues of the covering skin flap they were either left 
completely open, or completely closed, or were perforated to varying degrees. It was found 
that devices, which were open towards the soft tissue, led to pronounced soft tissue collapse 
into the space within the devices. 
In the present study, at 21 days, the highest percentage of newly formed bone was found in 
the PEG membrane group. Statistically significant differences were only found between the 
PEG membrane group and the collagen group. Several reasons may explain the small 
differences between the groups and the relatively good results obtained by the collagen 
sponge without a membrane and by the untreated defects at 10 and 21 days. Acute and not 
chronic defects were prepared. Acute defects have a high potential to form bone as a biologic 
reaction to the trauma (Schenk 1992). All 5 surrounding bone walls consisted of cancellous 
bone with exposed bone marrow, which are the primary source for angiogenic and osteogenic 
cells (Frost 1963, Schenk et al. 1994). The dimensions of the defects in the present study were 
on the one hand large enough to allow soft tissue collapse during early healing. On the other 
hand, during later phases the defects healed well with new bone formation even in the control 
groups. These rather favorable conditions regarding bone healing could explain the minor 
differences observed between the tested treatment modalities. 
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Interestingly, bone formation on top of the alveolar crest was observed around and in the 
vicinity of the pins. This new bone formation was not associated with the experimental 
defects but located on the buccal and lingual aspects of the ridge. Bone had formed between 
the external cortical bone plate and the periosteum, which had been elevated and repositioned 
in these areas. Several other studies have demonstrated bone formation underneath the 
periosteum following flap elevation (Cohen & Lacroix 1955, Elbeshir 1990, Lemperle et al. 
1998, Weng et al. 2000). It is generally assumed that the periosteum itself may have worked 
as a barrier membrane in these areas.  
At 2 months, the tested parameters (soft tissue ingrowth, bone regeneration) revealed no 
statistically significant differences between the test and the control groups. Complete bone fill 
was observed for all treatment modalities. Bone marrow was visible within the original 
defects. Moreover, bone apposition over the original level of the bone crest was observed in 
all sites. These results are in agreement with results from previous studies, where different 
filling materials and barrier membranes were evaluated in bone defects in minipigs (Buser et 
al. 1998). At 24 weeks of healing, all 5 filling materials showed similar values. The sites with 
collagen sponge and with blood clots demonstrated the same healing at 12 weeks, with the 
defects almost completely filled with new bone. Although that animal study was conducted in 
the mandibular angle and not on the mandibular ridge as in the present study, the anatomical 
situations are comparable. In both studies the surrounding bone walls consisted of cancellous 
bone and the elevated flaps were readapted for complete closure of the prepared bone defects. 
Obviously, both models exhibit similar potential for bone and soft tissue healing. Similar 
findings were also demonstrated in a recent preclinical study, where different membrane types 
were investigated for use in GBR procedures (Strietzel et al. 2006). In standardized defects in 
the pig mandible the barrier function of resorbable and non-resorbable membranes was tested. 
The defects revealed well-vascularized cancellous bone at 8 weeks, and bone healing was 
completed in all groups at 12 weeks (Strietzel et al. 2006). 
 
CONCLUSIONS 
 
The experimental PEG membrane applied in the present study successfully prevented collapse 
of the covering soft tissues to a degree similar to the PLA membrane. The combination of a 
collagen sponge and the PEG membrane showed the least soft tissue ingrowth at 10 days and 
promoted more bone formation at 21 days. Within the limits of this study, the experimental 
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PEG membrane can successfully be applied to prevent soft tissue ingrowth and to promote 
bone formation. More research is demanded for the use of this experimental membrane in 
more challenging defects. 
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Table 1. Descriptive statistics. Histomorphometric parameters in the 10 days group (n=5) 
Treatment Soft tissue 
ingrowth into 
bone defect 
 
(mm) 
Ratio of soft tissue 
area ingrowth to 
original defect 
area 
(%) 
Most apical point 
of soft tissue 
ingrowth 
 
(mm) 
Ratio of area of 
newly formed 
bone to original 
defect area 
(%) 
 mean±SD mean±SD mean±SD mean±SD 
Empty 0.34 ± 1.14 13.0 ± 16.3 2.14 ± 2.79 2.3 ± 1.4 
Collagen 0.30 ± 0.77 12.4 ± 15.7 2.14 ± 2.74 3.2 ± 1.0 
PLA 
membrane 
-0.16 ± 0.26 1.2 ± 1.9 0.20 ± 0.86 1.5 ± 0.01 
PEG 
membrane 
-0.75 ± 0.18 -0.3 ± 0.1 -0.93 ± 0.63 1.5 ± 1.0 
 
 
 
Table 2. Descriptive statistics. Histomorphometric parameters in the 21 days group (n=5) 
Treatment Soft tissue 
ingrowth into 
bone defect 
 
(mm) 
Ratio of soft tissue 
area ingrowth to 
original defect 
area 
(%) 
Most apical point 
of soft tissue 
ingrowth 
 
(mm) 
Ratio of area of 
newly formed 
bone to original 
defect area 
(%) 
 mean±SD mean±SD mean±SD mean±SD 
Empty 0.32 ± 0.45 9.7 ± 8.1 3.20 ± 1.17 18.3 ± 4.8 
Collagen 0.90 ± 0.31 21.5 ± 6.0 4.59 ± 1.91 17.9 ± 3.0 
PLA 
membrane 
0.62 ± 1.04 13.8 ± 15.2 2.26 ± 2.10 23.5 ± 11.6 
PEG 
membrane 
0.20 ± 0.16 6.5 ± 4.9 1.54 ± 0.80 29.1 ± 13.2 
 
 
 
Table 3. Descriptive statistics. Histomorphometric parameters in the 2 months group (n=6) 
Treatment Soft tissue 
ingrowth into 
bone defect 
 
(mm) 
Ratio of soft tissue 
area ingrowth to 
original defect 
area 
(%) 
Most apical point 
of soft tissue 
ingrowth 
 
(mm) 
Ratio of area of 
newly formed 
bone to original 
defect area 
(%) 
 mean±SD mean±SD mean±SD mean±SD 
Empty -0.64 ± 0.58 -4.4 ± 13.1 0.22 ± 0.95 52.3 ± 18.9 
Collagen -0.94 ± 0.43 -14.4 ± 16.7 -0.13 ± 0.74 67.1 ± 16.4 
PLA 
membrane 
-0.87 ± 0.54 -17.8 ± 25.4 0.30 ± 0.99 64.6 ± 18.9 
PEG 
membrane 
-0.86 ± 0.60 -11.0 ± 15.7 -0.68 ± 0.93 61.9 ± 19.0 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Defect preparation (diameter 8mm / depth 8mm) 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Empty defect & collagen sponge 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. Empty defect & PEG membrane 
 
 
 
 
 
 
 
 
 
 
Fig. 4. PLA membrane & collagen sponge 
 
 
 
 
Fig. 5. Histomorphometry (PLA membrane at 21 days). al: original level of bone crest; bl: 
level of soft tissue; d: border of original defect; ma: most apical point of soft tissue ingrowth; 
m1, m2, m3, m4, m5: five vertical measurements taken between the level of the original bone 
crest and the most apical limit of soft tissue ingrowth at equal intervals (negative values for 
m1 and m2, and positive values for m3, m4, and m5 in this example). 
 
 
 
 
 
 
 
 
Fig. 6. Histology at 10 days. From left to right: PEG membrane, PLA membrane, collagen 
sponge, empty defect. 
 
 
 
 
 
 
 
Fig. 7. Histology at 21 days. From left to right: PEG membrane, PLA membrane, collagen 
sponge, empty defect. 
 
 
 
Fig. 8. Histology at 2 months. From left to right: PEG membrane, PLA membrane, collagen 
sponge, empty defect. 
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Fig. 9. Multivariate analysis. Association between soft tissue ingrowth and treatment adjusted 
for the effect of individual and side factors. Whiskers indicate 95% confidence intervals. PEG 
membrane to empty comparison at 10 days. p-value=0.0283 (Dunnett-Hsu adjusted) 
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Fig. 10. Multivariate analysis. Association between the ratio of soft tissue area to original 
defect area and treatment adjusted for the effect of individual and side factors. Whiskers 
indicate 95% confidence intervals. PEG membrane to empty comparison at 10 days: p-
value=0.1207 (Dunnett-Hsu adjusted) 
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Fig. 11. Multivariate analysis. Association between the ratio of bone regeneration area to 
original defect area and treatment adjusted for the effect of individual and side factors. 
Whiskers indicate 95% confidence intervals. PEG membrane to collagen comparison at 21 
days: p-value=0.0325 (Dunnett-Hsu adjusted) 
 
 
